BMC Medical Co

BMC Medical Co R&D per Employee

The R&D Spending per Employee of BMC Medical Co (301367.SZ) as of Oct 26, 2026 is 165,034.27 CNY. In the previous year, R&D Spending per Employee was 147,833.23 CNY — a change of 11.64% (higher).

R&D per Employee

165,034.27CNY

YoY

11.64%

Last updated:

R&D Spending per Employee of BMC Medical Co is 2025 165,034.27 CNY. R&D Spending per Employee of BMC Medical Co was 2024 147,833.23 CNY. It decreases by 11.64% higher compared to the previous year.

The BMC Medical Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
27,590.63 CNY
Jan 1, 2020
39,911.56 CNY
Jan 1, 2021
57,272.01 CNY
Jan 1, 2022
86,433.00 CNY
Jan 1, 2023
138,761.97 CNY
Jan 1, 2024
147,833.23 CNY
Jan 1, 2025
165,034.27 CNY
The BMC Medical Co R&D per Employee history
YEARR&D per EmployeeYoY
165,034.27CNY+11.64%
147,833.23CNY+6.54%
138,761.97CNY+60.54%
86,433.00CNY+50.92%
57,272.01CNY+43.50%
39,911.56CNY+44.66%
27,590.63CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BMC Medical Co Stock analysis

What does BMC Medical Co do? BMC Medical Co. Ltd. generates revenue through the research, development, production, and sale of medical equipment and consumable products focused on respiratory health. The company offers non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices. Its primary customers are patients with sleep apnea-hypopnea syndrome (SAHS), particularly obstructive sleep apnea syndrome (OSA), and patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD). The firm provides chronic disease management services as part of its full-cycle treatment solutions. The company's product portfolio includes non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices, all designed for respiratory health applications. These products target patients suffering from OSA and COPD, addressing both acute and chronic respiratory conditions. BMC Medical Co. Ltd. focuses on delivering comprehensive treatment services through a multi-scenario approach for these specific patient segments. Revenue streams are derived from the sale of medical equipment and consumables, as well as chronic disease management services. The company's services are tailored for patients with SAHS and COPD, providing integrated solutions across the treatment cycle. This includes both the physical products and the ongoing management support for long-term respiratory health needs. BMC Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BMC Medical Co stock

R&D Spending per Employee of BMC Medical Co is 165,034.27 CNY in 2025.

R&D Spending per Employee of BMC Medical Co changed from 147,833.23 CNY to 165,034.27 CNY, representing a 11.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee BMC Medical Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's BMC Medical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — BMC Medical Co

All Key Metrics — BMC Medical Co